# OnCo record nct07005102 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07005102/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07005102", "NCT07005102" ;
  schema:name "A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer"@en ;
  schema:description "A phase 2/3 trial testing Telisotuzumab adizutecan in non-small-cell lung cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07005102/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07005102> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2025-08-03" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:drugs <https://onco.cc/drugs/telisotuzumab-adizutecan/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .